RSLV-132
- Generic Name
- RSLV-132
Therapeutic Trials for Long COVID-19: A Call to Action
The article discusses the ongoing challenges and research efforts in understanding and treating Long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC). It highlights the need for therapeutic trials to address the persistent symptoms affecting a significant number of individuals post-acute SARS-CoV-2 infection. The National Institutes of Health's RECOVER initiative is mentioned as a key effort in this area, focusing on understanding the biological mechanisms behind Long COVID and exploring potential treatments.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath